Suven Life Sciences responds to stock exchange queries on recent price and volume movement in its scrip.
The company confirms it has no material events pending disclosure under SEBI LODR Regulation 30.
Attributes the recent price/volume movement solely to market speculation with no further comment.
Requests stock exchanges to disseminate this clarification on their websites and company's website.